BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Interviews
  • Products
  • Submit PR
  • Home
  • COVID-19
  • Submit PR
  • Stem Cells
  • Exosomes
  • Cell Therapy
  • Cord Blood
  • Stem Cell News
  • Interviews
  • HSCs
  • iPS Cells
  • MSCs
  • Neural Stem Cells
  • Adipose SCs
  • CAR-T
  • Advertise
  • Story
  • Job Posts
Home » المنتجات » Reach BioInformant’s Audience with Your Press Announcement
تخفيض!
BioInformant Audience

Reach BioInformant’s Audience with Your Press Announcement

التصنيفات: Cord Blood, Stem Cells الوسوم: press release, social media
  • الوصف

الوصف

With BioInformant’s traffic nearing one million viewers per year, would you like to place your press release in front of these targeted readers?

Do you have a press announcement relevant to the stem cell industry? If you are an avid reader of BioInformant and it is relevant to our readers that follow us for stem cell industry news, then we would be honored to get it industry-wide attention.

Discover class-defining bioproduction tools.

As reported by Google Analytics, BioInformant.com attracts over 64,400+ unique viewers per month, which is nearly one million views per year.

We will leverage for you the same strategies and distribution channels that have grown BioInformant into the world’s largest publisher of stem cell industry news.

These audience channels are how you came to know about us, so we are confident that we can get industry wide recognition for you too.

Access BioInformant’s Targeted Audience

When you partner with us, we publish your announcement to BioInformant.com to reach our online readers and distribute it across all of our other audience channels as well.

These audience channels include:

  • Online readers of BioInformant.com (Nearly one million viewers per year)
  • 28,000+ LinkedIn followers
  • 21,200+ Twitter followers
  • 4,100+ Facebook followers
  • 37,000+ Email Subscribers
  • 175,000+ Members of LinkedIn Groups
  • Search Engine Optimization (SEO) to drive daily Google traffic

BioInformant’s Strategic Distribution

One of BioInformant’s strengths is that we are experts at digital marketing. It is how we grew our site from no traffic to nearly a million views per year.

As mentioned above, we will feature your press release in our Email Newsletter to 25,700+ stem cell industry subscribers. This will get it targeted visibility by delivering your news to the inbox of stem cell industry participants worldwide.

We also control hundreds of stem cell terms on Google (1st page results) using Search Engine Optimization (SEO) techniques. We will also optimize your announcement to rank high within Google Search results.

This will drive continuous, daily traffic, positioning your news release to act as an evergreen asset.

In addition to leveraging our own audience channels, we will post your announcement to targeted LinkedIn Groups to reach another 175,000+ readers, including:

  • Biotech & Pharma Professionals Network (89,965 members)
  • Biotechnology/Pharmaceuticals – 61,576 members
  • Clinical Development and Innovation (13,900 Members)
  • Regenerative Medicine Group – 6,400 Members
  • Stem Cells and Regenerative Medicine (3,800 Members)
  • And many more

Because our Founder, Cade Hildreth, B.A., M.S., in a Top Contributor to numerous LinkedIn groups, our posts often get emailed out by LinkedIn to all group members.

It is also valuable to have a third-party share the content on your behalf, because it builds credibility in comparison to posting it yourself.

Immediate Industry-Wide Recognition

These are the same strategies and distribution channels that we used to grow BioInformant into the world’s largest publisher of stem cell industry news in a brief period of time.

For this reason, we are confident we can get your industry-wide attention too.

Click here to see press announcements for company leaders we represent across the stem cell industry or view Client Testimonials.

Spread Your Stem Cell Industry News, Guaranteed

For a limited-time, this service is available for only $297 (25% off). Get your announcement immediate visibility by tapping into BioInformant’s large and targeted audience.

To partner with us for distribution of your announcement, checkout below and send your press release to our team at Info@BioInformant.com.

Of course, your investment is backed by a 60-Day Money Back Guarantee.

$397 $297

منتجات ذات صلة

  • تخفيض! Dental Stem Cell Storage Market

    Key Competitors in the Dental Stem Cell Storage Market [Market Brief + Database]

    $79 $49
    إضافة إلى السلة
  • تخفيض! stem cell physicians

    Database of Stem Cell Treatment Providers (400+ Clinics)

    $249 $125
    إضافة إلى السلة
  • Global Database of Research Supply Companies

    Global Database of Research Supply Companies 2021

    $39
    إضافة إلى السلة
  • تخفيض! Exosome Companies 2020

    Global Database of Exosome Companies

    $149 $97
    إضافة إلى السلة

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
تغريداتي

BioInformant's World-Class Clients

  • Reach BioInformant’s Audience with Your Press Announcement

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.